FDA classifies t:slim X2 insulin pump first in new device category for Alternate Controller Enabled Infusion Pumps (ACE pumps) ...

The Food and Drug Administration has assigned its most serious classification to the recall of 17,000 electronic infusion pumps made by CareFusion, saying a flaw in the devices could case serious i… ...

Volumetric pump segment accounts for the largest market share of 37.1%, of the global infusion pump market by type. This major share is mainly attributed to the factors such as; high popularity of the ...

Tubeless insulin pump market is anticipated to grow at 23.4% CAGR, from $527.8 million in 2018 and will generate a revenue of $2,837.6 million by 2026.

In addition, approximately 125,000 Americans with type 2 diabetes use an insulin pump, a small fraction of the type 2 diabetes population. About Tandem Diabetes Care, Inc.

The FDA granted de novo classification to the Fysx ocular pressure adjusting pump for patients with normal-tension glaucoma or open-angle glaucoma with IOP of 21 mm Hg or less, according to a ...